Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002915072 | SCV003269079 | likely benign | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002942237 | SCV003678463 | likely benign | Inborn genetic diseases | 2022-02-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV002915072 | SCV003799475 | uncertain significance | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing | The PIEZO1 c.1187G>A; p.Arg396Gln variant (rs764722890), to our knowledge, is not reported in the medical literature or gene specific databases. This variant is found in the general population with an overall allele frequency of 0.05% (79/168978 alleles). The arginine at codon 396 is weakly conserved, and computational analyses predict that this variant is neutral (REVEL: 0.076). Due to limited information, the clinical significance of this variant is uncertain at this time. |